NCT03373903View on ClinicalTrials.gov

Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

652

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

May 3, 2018

Study Completion Date

July 31, 2018

Conditions

Respiratory Tract Infections

Interventions

OTHER

Placebo

oral

DRUG

BEZ235

oral

DRUG

BEZ235 plus everolimus (RAD001)

Oral

Trial Locations (1)

67205

Heartland Research Associates, Wichita

All Listed Sponsors

lead

Restorbio Inc.

INDUSTRY